Abstract. Type 1 diabetics must inject exogenous insulin or insulin analogues one or more times daily. The timing and dosage of insulin administration have been a critical research area since the invention of insulin analogues. Several pharmacokinetical models have been proposed, and some are applied clinically in modeling various insulin therapies. However, their plasma insulin concen-tration must be computed separately from the models ’ output. Furthermore, minimal analytical study was performed in these existing models. We propose two systemic and simplified ordinary differential equation models to model the subcutaneous injection of rapid-acting insulin analogues and long-acting in-sulin analogues, respectively. Our models explicitly mo...
International audienceSeveral models have been developed for decades. These models have an inherent ...
Diabetes is a group of metabolic diseases characterized by hyperglycaemia resulting from defects in ...
International audienceA new glucose-insulin model is introduced which fits with the clinical data fr...
(Communicated by???) Abstract. In the last three decades, several models relevant to the subcuta-neo...
Subcutaneous insulin kinetics is a complex process whose quantitation is needed for a reliable glyce...
Despite the great progress made in insulin preparation and titration, many patients with diabetes ar...
Standard insulin therapy to treat type 1 diabetes (T1D) consists of exogenous insulin administration...
Medical scientists have various ways of handling cases of insulin-dependent diabetes diseases of whi...
Mathematical models based on advanced differential equations are utilized to analyze the effect of i...
Continuous subcutaneous insulin infusion is characterized by a basal insulin delivery rate to which ...
Standard insulin therapy to treat type 1 diabetes (T1D) consists of exogenous insulin administration...
The purpose of the research was to propound an insulin activity model in a human body after a subcut...
The purpose of the research was to propound an insulin activity model in a human body after a subcut...
Type 1 Diabetes is characterized by the destruction of the beta cells. The consequent insulin defici...
Type 2 diabetes is a complex chronic metabolic disorder characterized by hyperglycemia associated wi...
International audienceSeveral models have been developed for decades. These models have an inherent ...
Diabetes is a group of metabolic diseases characterized by hyperglycaemia resulting from defects in ...
International audienceA new glucose-insulin model is introduced which fits with the clinical data fr...
(Communicated by???) Abstract. In the last three decades, several models relevant to the subcuta-neo...
Subcutaneous insulin kinetics is a complex process whose quantitation is needed for a reliable glyce...
Despite the great progress made in insulin preparation and titration, many patients with diabetes ar...
Standard insulin therapy to treat type 1 diabetes (T1D) consists of exogenous insulin administration...
Medical scientists have various ways of handling cases of insulin-dependent diabetes diseases of whi...
Mathematical models based on advanced differential equations are utilized to analyze the effect of i...
Continuous subcutaneous insulin infusion is characterized by a basal insulin delivery rate to which ...
Standard insulin therapy to treat type 1 diabetes (T1D) consists of exogenous insulin administration...
The purpose of the research was to propound an insulin activity model in a human body after a subcut...
The purpose of the research was to propound an insulin activity model in a human body after a subcut...
Type 1 Diabetes is characterized by the destruction of the beta cells. The consequent insulin defici...
Type 2 diabetes is a complex chronic metabolic disorder characterized by hyperglycemia associated wi...
International audienceSeveral models have been developed for decades. These models have an inherent ...
Diabetes is a group of metabolic diseases characterized by hyperglycaemia resulting from defects in ...
International audienceA new glucose-insulin model is introduced which fits with the clinical data fr...